1. Metformin as a Therapeutic Target in Endometrial Cancers
   Teresa Y. Lee et al, 2018, Frontiers in Oncology CrossRef
2. TYRO3: A potential therapeutic target in cancer
   Pei-Ling Hsu et al, 2019, Experimental Biology and Medicine CrossRef
3. Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers
   Maria Isabella Sereni et al, 2017, British Journal of Cancer CrossRef
4. Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
   Mateusz Mieczkowski et al, 2021, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
5. SPARC Inhibits Metabolic Plasticity in Ovarian Cancer
   Christine Naczki et al, 2018, Cancers CrossRef
6. Metformin in Cervical Cancer: Metabolic Reprogramming
   Malgorzata Tyszka-Czochara et al, 2019, Metformin [Working Title] CrossRef
7. Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells
   Maritza P. Garrido et al, 2018, Therapeutic Advances in Medical Oncology CrossRef
8. Histological and biochemical investigation of the renoprotective effects of metformin in diabetic and prostate cancer model
   Pınar Koroglu-Aydın et al, 2021, Toxicology Mechanisms and Methods CrossRef
9. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
   Reetta Arima et al, 2017, Gynecologic Oncology CrossRef
10. Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning
    Khader Shameer et al, 2018, Briefings in Bioinformatics CrossRef
11. Metaformin-Based Regimen Inhibits Glucose Uptake and G6PD Activity: A de novo Anti-cervical Cancer Strategy Tackles HeLa and its Derivative Hep2 Cells
    Ahmed A. Abd-Rabou et al, 2017, Journal of Pharmacology and Toxicology CrossRef
12. Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer
    Anna Markowska et al, 2017, European Journal of Medicinal Chemistry CrossRef
13. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
    Siddhartha Dutta et al, 2023, Drug Design, Development and Therapy CrossRef
14. Low-Dose Metformin as a Monotherapy Does Not Reduce Non-Small-Cell Lung Cancer Tumor Burden in Mice
    Nicole L. Stott Bond et al, 2021, Biomedicines CrossRef
15. Protective and therapeutic effects of metformin on gynecologic cancers
    Jee Young Hwang, 2016, Journal of Gynecologic Oncology CrossRef
16. Metformin as a Potential Treatment Option for Endometriosis
    Żaneta Kimber-Trojnar et al, 2022, Cancers CrossRef
17. Low-Dose Metformin Treatment Reduces In Vitro Growth of the LL/2 Non-small Cell Lung Cancer Cell Line
    Nicole L. Stott Bond et al, 2022, Biomedicines CrossRef
18. Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia
    Jian Wang et al, 2019, Journal of Pediatric Hematology/Oncology CrossRef
19. Why Metformin Is so Important for Prevention and Therapy in Climacteric Women
    Justyna Kuliczkowska-Plaksej et al, 2018, Pre-Menopause, Menopause and Beyond CrossRef
20. Controlled release of anti-diabetic drug metformin hydrochloride from cellulose/PEG/poly (SA) ter-polymeric hydrogels
    S. K. Bajpai et al, 2017, Journal of Macromolecular Science, Part A CrossRef
21. Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer
    Anil Belur Nagaraj et al, 2018, Gynecologic Oncology CrossRef
22. Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer
    Luxitaa Goenka et al, 2022, American Journal of Clinical Oncology CrossRef
23. Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
    Matilda Lee et al, 2019, Redox Biology CrossRef
24. Molecular and Cellular Mechanisms of Metformin in Cervical Cancer
    Ya-Hui Chen et al, 2021, Cancers CrossRef